MB

Michael Baker

Arovella Therapeutics Limited | Chief Executive Officer, Managing Director
Dr Baker has over 15 years of experience in scientific research, drug developmentand venture investing. He was an Investment Manager with leading Australian life science fund, BioScience Managers, responsible for deal sourcing form networks, conferences, universities, and research institutes. He also conducted due diligence to shortlist investment opportunities and played an active role in managing portfolio companies.

Company and Roles

Company
Title
Tenure
Since
ALA
ALA
Arovella Therapeutics Limited
  • Chief Executive Officer
  • Managing Director
4yrs, 8mthJan 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ALA
ALA
Arovella Therapeutics Limited
27/03/2406,567,47210,178,531N/A
RAD
RAD
08/12/23N/A117,4111,906,262N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ALA
ALA
Arovella Therapeutics Limited
27/03/24
Buy
220,000$0.142$31,289On-market trade
ALA
ALA
Arovella Therapeutics Limited
29/12/23
Exercise
2,800,000$0.115$322,000Exercise of options
ALA
ALA
Arovella Therapeutics Limited
29/12/23
Buy
587,824$0.115$67,599Exercise of options
RAD
RAD
08/12/23
Issued
71,428$0.070$4,999Rights issue
ALA
ALA
Arovella Therapeutics Limited
04/12/23
Issued
2,178,531$0.088$191,710Issue of options